<p>Ascletis Pharma Inc. has filed a next day disclosure return with the Hong Kong Stock Exchange, reporting the repurchase of 100,000 shares at a total aggregate price of HKD 1,254,850. The repurchased shares are to be cancelled in accordance with the company’s share buyback mandate. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251224-11966555), on December 24, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

01672

<p>Ascletis Pharma Inc. has disclosed to the Hong Kong Stock Exchange the repurchase of 100,000 shares for HKD 1,254,850. The shares will be cancelled as part of the company's buyback mandate. This announcement was made via the Issuer Information Service of HKEX.</p>

Ascletis Pharma Files HKEX Disclosure on Repurchase of 100,000 Shares at HKD 1,254,850